Fyremadel 0.25 mg/0.5 ml injection solution ready-to-use, 5pcs

The medicine contains the active ingredient Ganirelix and belongs to a group of medicines called “gonadotropin-releasing hormone antagonists”, which inhibit the effects of the natural gonadotropin-releasing hormone (GnRH). GnRH regulates the release of gonadotropins (luteinizing hormones). Hormone [LH] and follicle-stimulating hormone [FSH]) play an important role in human fertility and reproduction. In women, FSH is responsible for the growth and development of the follicles in the ovaries. which the eggs contain. LH is required for the release of mature eggs from the follicles and ovaries (ovulation). The drug prevents the effect of GnRH; this particularly inhibits the release of LH.